Skip to main content

Advertisement

SpringerLink
Log in

Accuracy of One-Step Nucleic Acid Amplification in Detecting Lymph Node Metastases in Endometrial Cancer

  • Review
  • Published:
Pathology & Oncology Research

Abstract

One-step nucleic acid amplification (OSNA) is used to intraoperatively detect sentinel lymph node metastases in breast cancer. OSNA has also been proposed in endometrial cancer, but evidence in this regard is unclear to define the diagnostic accuracy of OSNA in detecting lymph node metastases in endometrial cancer. A systematic review and meta-analysis was performed by searching 8 electronic databases from their inception to March 2019 for studies testing the diagnostic accuracy of OSNA in detecting sentinel lymph node metastasis in endometrial cancer. Pathologic ultrastaging was the reference standard. Sensitivity, specificity, positive and negative likelihood ratio (LR+ and LR-), diagnostic odds ratio (DOR) and area under the curve (AUC) on SROC curve were calculated. Four studies with 237 patients and 691 lymph nodes were included. OSNA showed sensitivity = 0.88, specificity = 0.93, LR + =17.95, LR- = 0.15, DOR = 191.23 and high diagnostic accuracy (AUC = 0.959). OSNA appears as a highly accurate tool for intraoperative assessment of sentinel lymph node in endometrial cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Globocan, Northern America, WHO Europe Region (EURO). Estimated cancer incidence, all ages: female. 2012. Accessed January 23, 2017

  2. Travaglino A, Raffone A, Saccone G, Insabato L, Mollo A, de Placido G, Zullo F (2018) PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 231:104–110

    CAS  PubMed  Google Scholar 

  3. Travaglino A, Raffone A, Saccone G, de Luca C, Mollo A, Mascolo M, de Placido G, Insabato L, Zullo F (2019) Immunohistochemical nuclear expression of β-catenin as a surrogate of CTNNB1 exon 3 mutation in endometrial Cancer. Am J Clin Pathol 151(5):529–538

    CAS  PubMed  Google Scholar 

  4. Travaglino A, Raffone A, Saccone G, Insabato L, Mollo A, de Placido G, Zullo F (2019) Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review. Acta Obstet Gynecol Scand. https://doi.org/10.1111/aogs.13587 [Epub ahead of print]

  5. Giampaolino P, Di Spiezio SA, Mollo A et al (2019) Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study. J Minim Invasive Gynecol 26(4):648–656

    PubMed  Google Scholar 

  6. Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105(2):109–109

    PubMed  Google Scholar 

  7. Raffone A, Travaglino A, Saccone G, Mollo A, de Placido G, Insabato L, Zullo F (2019) Should progesterone and estrogens receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis. Acta Obstet Gynecol Scand 98:976–987. https://doi.org/10.1111/aogs.13586. [Epub ahead of print]

    Article  CAS  PubMed  Google Scholar 

  8. Lewin SN, Wright JD (2011) Comparative performance of the 2009 international federation of gynecology and obstetrics’ staging system for uterine corpus cancer. Obstet Gynecol 117(5):1226

    PubMed  Google Scholar 

  9. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. NCCN Guidelines Version 2.2018 Uterine Neoplasms

  10. Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C, ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group (2016) ESMO-ESGO-ESTRO consensus conference on endometrial Cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 26(1):2–30

    PubMed  Google Scholar 

  11. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet (London, England) 373(9658):125–136

    CAS  Google Scholar 

  12. Chambers LM, Vargas R, Michener CM (2019) Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists. J Gynecol Oncol 30(3):e35

    PubMed  Google Scholar 

  13. Lin H, Ding Z, Kota VG, Zhang X, Zhou J (2017) Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Oncotarget. 8(28):46601–46610

    PubMed  PubMed Central  Google Scholar 

  14. Bodurtha Smith AJ, Fader AN, Tanner EJ (2017) Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 216(5):459–476.e10

    PubMed  Google Scholar 

  15. Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J, Mueller MD, Panici PB, Papadia A (2016) Sentinel node mapping in cervical and endometrial Cancer: Indocyanine green versus other conventional dyes-a meta-analysis. Ann Surg Oncol 23(11):3749–3756

    PubMed  Google Scholar 

  16. Ansari M, Rad MA, Hassanzadeh M, Gholami H, Yousefi Z, Dabbagh VR, Sadeghi R (2013) Sentinel node biopsy in endometrial cancer: systematic review and meta-analysis of the literature. Eur J Gynaecol Oncol 34(5):387–401

    CAS  PubMed  Google Scholar 

  17. How JA, O'Farrell P, Amajoud Z, Lau S, Salvador S, How E, Gotlieb WH (2018) Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Minerva Ginecol 70(2):194–214

    PubMed  Google Scholar 

  18. Daraï E, Dubernard G, Bats AS, Heitz D, Mathevet P, Marret H, Querleu D, Golfier F, Leblanc E, Rouzier R, Ballester M (2015) Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study. Gynecol Oncol 136(1):54–59

    PubMed  Google Scholar 

  19. Bézu C, Coutant C, Ballester M, Feron JG, Rouzier R, Uzan S, Daraï E (2010) Ultrastaging of lymph node in uterine cancers. J Exp Clin Cancer Res 29:5

    PubMed  PubMed Central  Google Scholar 

  20. Torné A, Puig-Tintoré LM (2004) The use of sentinel lymph nodes in gynaecological malignancies. Curr Opin Obstet Gynecol 16(1):57–64

    PubMed  Google Scholar 

  21. Holloway RW, Abu-Rustum NR, Backes FJ, Boggess JF, Gotlieb WH, Jeffrey Lowery W, Rossi EC, Tanner EJ, Wolsky RJ (2017) Sentinel lymph node mapping and staging in endometrial Cancer: a Society of Gynecologic Oncology Literature Review with consensus recommendations. Gynecol Oncol 146(2):405–415

    PubMed  PubMed Central  Google Scholar 

  22. Kosťun J, Pešta M, Sláma J, Slunéčko R, Vlasák P, Bouda J, Novotný Z, Topolčan O, Kučera R, Kulda V, Houfková K, Berezovskiy D, Bartáková A, Presl J (2019) One-step nucleic acid amplification vs ultrastaging in the detection of sentinel lymph node metastasis in endometrial cancer patients. J Surg Oncol 119(3):361–369

    PubMed  Google Scholar 

  23. Slama J, Dundr P, Dusek L, Cibula D (2013) High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 129(2):384–388

    CAS  PubMed  Google Scholar 

  24. Zhou M, Wang X, Jiang L, Chen X, Bao X, Chen X (2018) The diagnostic value of one step nucleic acid amplification (OSNA) in differentiating lymph node metastasis of tumors: a systematic review and meta-analysis. Int J Surg 56:49–56

    PubMed  Google Scholar 

  25. Shi F, Liang Z, Zhang Q, Wang C, Liu X (2018) The performance of one-step nucleic acid amplification assay for intraoperative detection of sentinel lymph node macrometastasis in breast cancer: an updated meta-analysis. Breast. 39:39–45

    PubMed  Google Scholar 

  26. Shi F, Zhang Q, Liang Z, Zhang M, Liu X (2017) One-step nucleic acid amplification assay is an accurate technique for sentinel lymph node biopsy of breast cancer patients: a meta-analysis. Br J Cancer 117(8):1185–1191

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Nagai T, Niikura H, Okamoto S, Nakabayashi K, Matoda M, Utsunomiya H, Nagase S, Watanabe M, Takeshima N, Yaegashi N (2015) A new diagnostic method for rapid detection of lymph node metastases using a one-step nucleic acid amplification (OSNA) assay in endometrial cancer. Ann Surg Oncol 22(3):980–986

    PubMed  Google Scholar 

  28. Raffone A, Travaglino A, Saccone G, Insabato L, Mollo A, de Placido G, Zullo F (2019) Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis. Arch Gynecol Obstet 299(5):1233–1242

    PubMed  Google Scholar 

  29. Raffone A, Travaglino A, Saccone G, Viggiani M, Giampaolino P, Insabato L, Mollo A, de Placido G, Zullo F (2019) PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 299(6):1511–1524

    CAS  PubMed  Google Scholar 

  30. Travaglino A, Raffone A, Saccone G, Mollo A, de Placido G, Mascolo M, Insabato L, Zullo F (2019) Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia. APMIS. 127(6):427–434

    PubMed  Google Scholar 

  31. Raffone A, Travaglino A, Saccone G, Alviggi C, Mascolo M, de Placido G, Insabato L, Mollo A, Zullo F (2019) Management of women with atypical polypoid adenomyoma of the uterus: a quantitative systematic review. Acta Obstet Gynecol Scand 98(7):842–855

    PubMed  Google Scholar 

  32. Moher D, Shamseer L, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1

    PubMed  PubMed Central  Google Scholar 

  33. Sotiriadis A, Papatheodorou SI, Martins WP (2016) Synthesizing evidence from diagnostic accuracy tests: the SEDATE guideline. Ultrasound Obstet Gynecol 47(3):386–395

    CAS  PubMed  Google Scholar 

  34. Travaglino A, Raffone A, Saccone G, Insabato L, Mollo A, de Placido G, Zullo F (2018) Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: a specific marker of precancer and novel indication for treatment: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 97(12):1415–1426

    CAS  PubMed  Google Scholar 

  35. Travaglino A, Raffone A, Saccone G, Mollo A, de Placido G, Insabato L, Zullo F (2019) Endometrial hyperplasia and risk of coexistent cancer: WHO vs EIN criteria. Histopathology 74(5):676–687

    PubMed  Google Scholar 

  36. Raffone A, Travaglino A, Saccone G, Mascolo M, Insabato L, Mollo A, de Placido G, Zullo F (2019) PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia. A systematic review and meta-analysis of diagnostic accuracy. Acta Obstet Gynecol Scand 98(3):287–299

    CAS  PubMed  Google Scholar 

  37. Raffone A, Travaglino A, Saccone G, Campanino MR, Mollo A, de Placido G, Insabato L, Zullo F (2019) Loss of PTEN expression as diagnostic marker of endometrial precancer: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 98(3):275–286

    PubMed  Google Scholar 

  38. Travaglino A, Raffone A, Saccone G, Mascolo M, Pignatiello S, Mollo A, de Placido G, Insabato L, Zullo F (2019) PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer? APMIS 127(4):161–169

    CAS  PubMed  Google Scholar 

  39. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536

    PubMed  Google Scholar 

  40. Raffone A, Travaglino A, Saccone G, di Maio A, Mollo A, Mascolo M, de Rosa R, de Placido G, Insabato L, Zullo F (2019) Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment. Gynecol Endocrinol 5:1–6. https://doi.org/10.1080/09513590.2019.1624716 [Epub ahead of print]

    Article  Google Scholar 

  41. Raffone A, Travaglino A, Saccone G, D’Alessandro P, Arduino B, Mascolo M, de Placido G, Insabato L, Zullo F (2019) Diabetes mellitus is associated with occult Cancer in endometrial hyperplasia. Pathol Oncol Res. https://doi.org/10.1007/s12253-019-00684-3 [Epub ahead of print] Review

  42. López-Ruiz ME, Diestro MD, Yébenes L, Berjón A, Díaz de la Noval B, Mendiola M, de Santiago J, Hardisson D (2016) One-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastasis in endometrial cancer. Gynecol Oncol 143(1):54–59

    PubMed  Google Scholar 

  43. Fanfani F, Monterossi G, Ghizzoni V, Rossi ED, Dinoi G, Inzani F, Fagotti A, Gueli Alletti S, Scarpellini F, Nero C, Santoro A, Scambia G, Zannoni GF (2018) One-step nucleic acid amplification (OSNA): a fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer. PLoS One 13(4):e0195877

    PubMed  PubMed Central  Google Scholar 

  44. Fishman A, Klein A, Zemer R, Zimlichman S, Bernheim J, Cohen I, Altaras MM (2000) Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer. Gynecol Oncol 77(3):399–404

    CAS  PubMed  Google Scholar 

  45. Togami S, Kawamura T, Fukuda M, Yanazume S, Kamio M, Kobayashi H (2019) Quantitative RT-PCR assay for detecting lymph node metastasis in endometrial Cancer: a preliminary study. Oncology 96(4):179–182

    CAS  PubMed  Google Scholar 

  46. Ballester M, Naoura I, Chéreau E, Seror J, Bats AS, Bricou A, Daraï E (2013) Sentinel node biopsy upstages patients with presumed low- and intermediate-risk endometrial cancer: results of a multicenter study. Ann Surg Oncol 20(2):407–412

    PubMed  Google Scholar 

  47. Rozenholc A, Samouelian V, Warkus T et al (2019) Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer. Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2019.03.103 pii: S0090–8258(19)30296–3. [Epub ahead of print]

  48. Rossi EC (2019) Current state of sentinel lymph nodes for women with endometrial cancer. Int J Gynecol Cancer 29(3):613–621

    PubMed  Google Scholar 

  49. Liu LC, Lang JE, Lu Y, Roe D, Hwang SE, Ewing CA, Esserman LJ, Morita E, Treseler P, Leong SP (2011) Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience. Cancer. 117(2):250–258

    PubMed  Google Scholar 

  50. Silveberg SG (2007) The endometrium. Arch Pathol Lab Med 131:372–382

    Google Scholar 

  51. Tamaki Y (2017) One-step nucleic acid amplification (OSNA): where do we go with it? Int J Clin Oncol 22(1):3–10

    CAS  PubMed  Google Scholar 

  52. Americal Joint Committee on Cancer (AJCC) Cancer Staging Atlas. NY: Springer, 2017. 8th edition

  53. Raia-Barjat T, Trombert B, Khaddage A, Douchet C, Seffert P, Peoc’h M, Falk AT, Magné N, Chauleur C (2014) OSNA (one-step nucleic acid amplification) sentinel lymph node intraoperative molecular analysis in breast cancer: a cost-benefit analysis. Med Oncol 31(12):322

    PubMed  Google Scholar 

  54. Guillén-Paredes MP, Carrasco-González L, Cháves-Benito A, Campillo-Soto Á, Carrillo A, Aguayo-Albasini JL (2011) One-step nucleic acid amplification (OSNA) assay for sentinel lymph node metastases as an alternative to conventional postoperative histology in breast cancer: a cost-benefit analysis. Cir Esp 89(7):456–462

    PubMed  Google Scholar 

  55. Bogani G, Mariani A, Paolini B et al (2019) Low-volume disease in endometrial cancer: The role of micrometastasis and isolated tumor cells. Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2019.02.027 pii: S0090–8258(19)30137–4. [Epub ahead of print]

  56. Plante M, Stanleigh J, Renaud MC, Sebastianelli A, Grondin K, Grégoire J (2017) Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter? Gynecol Oncol 146(2):240–246

    PubMed  Google Scholar 

  57. St Clair CM, Eriksson AG, Ducie JA et al (2016) Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma. Ann Surg Oncol 23(5):1653–1659

    PubMed  Google Scholar 

  58. Tvedskov TF (2012) Staging of women with breast cancer after introduction of sentinel node guided axillary dissection. Dan Med J 59(7):B4475

    PubMed  Google Scholar 

  59. Raffone A, Travaglino A, Saccone G, Cieri M, Mascolo M, Mollo A, Insabato L, Zullo F (2019) Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer. APMIS 127(9):597–606

  60. Travaglino A, Raffone A, Saccone G, Mascolo M, D'Alessandro P, Arduino B, Mollo A, Insabato L, Zullo F (2019) Nuclear expression of β‐catenin in endometrial hyperplasia as marker of premalignancy. APMIs.

Download references

Author information

Authors and Affiliations

  1. Gynecology and Obstetrics Unit, Department of Neurosciences, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Via Sergio Pansini, 5, 80131, Naples, Italy

    Antonio Raffone & Italia Esposito

  2. Anatomic Pathology Unit, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy

    Antonio Travaglino

  3. Pathology Unit, Department of Woman and Child Health, Agostino Gemelli University Polyclinic, Catholic University of the Sacred Heart, Rome, Italy

    Angela Santoro, Giuseppe Angelico, Saveria Spadola & Gian Franco Zannoni

Authors
  1. Antonio Raffone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio Travaglino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angela Santoro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Italia Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giuseppe Angelico
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Saveria Spadola
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gian Franco Zannoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonio Raffone.

Ethics declarations

Conflict of Interest

The authors report no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raffone, A., Travaglino, A., Santoro, A. et al. Accuracy of One-Step Nucleic Acid Amplification in Detecting Lymph Node Metastases in Endometrial Cancer. Pathol. Oncol. Res. 26, 2049–2056 (2020). https://doi.org/10.1007/s12253-019-00727-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-019-00727-9

Keywords

Search

Navigation